Benign symmetric lipomatosis: functional sympathetic denervation of adipose tissue and possible hypertrophy of brown fat

ME Kodish, RN Alsever, MB Block - Metabolism, 1974 - Elsevier
ME Kodish, RN Alsever, MB Block
Metabolism, 1974Elsevier
Levels of lipolytic hormones (growth hormone, cortisol, and glucagon), insulin, and free fatty
acids were measured in a patient with benign symmetric lipomatosis during a 5-hr glucose
tolerance test, an insulin tolerance test, a 24-hr fast, and an epinephrine infusion. Although
there was no abnormality in insulin dynamics or impairment in lipolytic hormone secretion,
there was a failure of free fatty acid concentrations to rise to expected levels during fasting
and after glucose. Insulin hypoglycemia and epinephrine infusion resulted in normal and …
Abstract
Levels of lipolytic hormones (growth hormone, cortisol, and glucagon), insulin, and free fatty acids were measured in a patient with benign symmetric lipomatosis during a 5-hr glucose tolerance test, an insulin tolerance test, a 24-hr fast, and an epinephrine infusion. Although there was no abnormality in insulin dynamics or impairment in lipolytic hormone secretion, there was a failure of free fatty acid concentrations to rise to expected levels during fasting and after glucose. Insulin hypoglycemia and epinephrine infusion resulted in normal and excessive free fatty acid responses, respectively. This pattern of free fatty acid release is consistent with functional sympathetic denervation of adipose tissue. The lipomatous fat in benign symmetric lipomatosis is similar in distribution to the brown fat of human newborns and rodents that may hypertrophy after denervation. It is suggested that the lipomas in this disorder may represent such brown adipose tissue.
Elsevier